Contributor Page
Kasznar Leonardos
Email  |  Articles
Contact Details
Tel: +55 21 2136 4100
Fax: +55 21 2136 4200
Rua Teófilo Otoni 63 / 5° - 8 ° andares
Rio de Janeiro
By Tatiana Almeida Silveira, Gustavo José Ferreira Barbosa
This time, the measure consists of a cooperation agreement signed between the BPTO and the EPO by means of a PPH Pilot Program exclusively directed to inventions in the Medical Technology and the Chemistry areas.
By Rafael Lacaz Amaral
This inevitably raises the question of which one shall prevail when there is a conflict between parallel registrations of the same sign.
By Ricardo Cardoso Costa Boclin, Fabio Ferreira
Further to our newsletter 12/16, please be informed that the Brazilian Patent Office issued on 1.March 2017 the Resolution No. 179 revoking Resolution 174, which was addressed in said previous newsletter.
By Joao Luis D'Orey Facco Vianna, Edson Souza
The Brazilian Patent & Trademark Office has recently opened a new Public Consultation, this time on the draft guidelines for the examination of patent applications in the biotechnology field.
By Joao Luis D'Orey Facco Vianna, Edson Souza
The Brazilian FDA (ANVISA) has offered, for public consultation, a proposal of a new resolution relative to the prior consent proceedings applied to applications encompassing pharmaceutical products and processes, as set forth in Section 229-C of the Brazilian IP Law.
By Joao Luis D'Orey Facco Vianna, Sonis Moraes De Souza
As this is a very recent Resolution, when and how the BPTO will analyze such requests for belated entry into national phase in Brazil remains uncertain.